PMDA — authorised 14 January 2020
- Marketing authorisation holder: ViiV Healthcare K.K.
- Status: approved
🇯🇵 Epivir in Japan
PMDA authorised Epivir on 14 January 2020
Marketing authorisation
Epivir in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Epivir approved in Japan?
Yes. PMDA authorised it on 14 January 2020.
Who is the marketing authorisation holder for Epivir in Japan?
ViiV Healthcare K.K. holds the Japanese marketing authorisation.